p27Kip1 induces an accumulation of the repressor complexes of E2F and inhibits expression of the E2F-regulated genes

Molecular Biology of the Cell

Volumn 8, Issue 9, 1997, Pages 1815-1827

  Shiyanov, Pavel ^a   Hayes, Steven ^a   Chen, Ningyu ^a   Pestov, Dimitri G ^a   Lau, Lester F ^a   Raychaudhuri, Pradip ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REPRESSOR GENE;

ANIMALIA;

EID: 0030813562     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.8.9.1815     Document Type: Article

References (55)

1. Adams, P.D., Sellers, W.R., Sharma, S.K., Wu, A.D., Nalin, CM., and Kaelin, W.G., Jr. (1996). Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 26, 6623-6633.
2. Afshari, C.A., Nichols, M.A., Xiong, Y., and Mudryj, M. (1996). A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth & Differ. 7, 979-988.
3. Arroyo, M., Bagchi, S., and Raychaudhuri, P. (1993). Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol. Cell. Biol. 23, 6537-6546.
4. Ball, K.L., lain, S., Fahraeus, R., Smythe, C, and Lane, D.P. (1997). Cell-cycle arrest and inhibition of cdk4 activity by small peptides based on the carboxy-terminal domain of p2lWAFl. Curr Biol. 1, 71-80.
5. Beijersbergen, R.L., Kerkhoven, R.M., Zhu, L., Carlee, L., Voorhoeve, P.M., and Bernards, R. (1994). E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8, 2680-2690.
6. Blake, M., and Azizkhan, J.C. (1989). Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9, 4994-5002.
7. Chen, J., Saha, P., Kornbluth, S., Dynlacht, B.D., and Dutta, A. (1996). Cyclin-binding motifs are essential for the function of p21Cipl. Mol. Cell. Biol. 16, 4673-4682.
8. kipl for restriction point control of the fibroblast cell cycle. Science 272, 877-880.
9. Cobrinik, D., Whyte, P., Peeper, D., Jacks, T., and Weinberg, R. (1993). Cell cycle-specific association of E2F with p130 ElA-binding protein. Genes Dev. 7, 2392-2404.
10. 1S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
11. Dynlacht, B.D., Flores, O., Lees, J.A., and Harlow, E. (1994). Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes Dev. 8, 1772-1786.
12. kip1 deficient mice. Cell 85, 733-744.
13. Firpo, E., Koff, A., Solomon, M, and Roberts J.M. (1994). Inactivation of a cdk2 inhibitor during IL-2 induced proliferation of human T-lymphocytes. Mol. Cell. Biol. 14, 4889-4901.
14. Foteder, R., Fitzgerald, P., Rouselle, T., Cannella, D., Doree, M., Messier, H., and Foteder, A. (1996). p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12, 2155-2164.
15. Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R. (1993). Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349-352.
16. Ikeda, M., Jakoi, L., and Nevins, J.R. (1996). A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93, 3215-3220.
17. kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
18. kip1. Cell 85, 721-732.
19. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J., and Massague, J. (1993). Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 536-539.
20. Krek, W., Ewen, M.E., Shirodkar, S., Arany, Z., Kaelin, W.G., and Livingston, D.M. (1994). Negative regulation of the growth promoting transcription factor E2F1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161-172.
21. LaBaer, J., Garret, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A., and Harlow, E. (1997). New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862.
22. Labow, M.A., Baim, S.B., Shenk, T., and Levine, A.J. (1990). Conversion of the lac represser into an allosterically regulated transcriptional activator for mammalian cells. Mol. Cell. Biol, 10, 3343-3356.
23. Lee, M.-H., Mori, S., and Raychaudhuri, P. (1996). Trans-activation by the hnRNP K protein involves an increase in RNA synthesis from the reporter genes. J. Biol. Chem. 272, 3420-3427.
24. Means, A.L., Slansky, J.E., McMahon, S.L., Knuth, M.W., and Farhnam, P.J. (1992). The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol. Cell. Biol. 22, 1054-1063.
25. Moberg, K., Starz, M.A., and Lees, J.A. (1996). E2F4 switches from p130 to p107 and pRb in response to cell cycle entry. Mol. Cell. Biol. 26, 1436-1449.
26. Morozov, A., Phelps, W.C., and Raychaudhuri, P. (1994). Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60. J. Biol. Chem. 269, 18434-18440.
27. Morozov, A., Subjeck, J., and Raychaudhuri, P. (1995). HPV16 E7 oncoprotein induces expression of a 110 kD heat shock protein. FEBS Lett. 371, 214-218.
28. 1 arrest induced by serum-starvation and by the cell cycle inhibitor p21. J. Virol. 72, 3451-3457.
29. Nevins, J.R. (1992). E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 250, 424-429.
30. kip1 cyclin-Cdk kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
31. Ohtani, K., DeGregori, J., and Nevins, J.R. (1995). Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92, 12146-12150.
32. Pestov, D.G., and Lau, L.F. (1994). Genetic selection of growth-inhibitory sequences in mammalian cells. Proc. Natl. Acad. Sci. USA 91, 12549-12553.
33. kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
34. kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
35. Poon, R.Y.C., Toyoshima, H., and Hunter T. (1995). Redistribution of the CDK inhibitor between cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with Lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6, 1197-1213.
36. Reynisdottir, I., Polyak, K., Lavarone, A., and Massague, J. (1995). Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831-1845.#
37. Roberts, J.M., Koff, A., Polyak, K., Firpo, E., Colins, S., Ohtsubo, M., and Massague, J. (1994). Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harbor Symp. Quant. Biol. 59, 31-38.
38. Sardet, C., Vidal, M., Cobrinik, C., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R. (1995). E2F-4, and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92, 2403-2407.
39. Sellers, W.R., Rodgers, J.W., and Kaelin, W.G., Jr. (1995). A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92, 11544-11548.
40. 1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
41. Shiyanov, P., Bagchi, S., Adami, G.R., Kokontis, J., Hay, N., Arroyo, M., Morozov, A., and Raychaudhuri, P. (1996). P21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol. 16, 737-744.
42. Slansky, J.E., Li, Y., Kaelin, W.G., and Farnahm, P.J. (1993). A protein synthesis dependent increase in E2F1 mRNA correlates with growth regulation of the DHFR promoter. Mol. Cell. Biol. 13, 1610-1618.
43. Slingerland, J., Hengst, L., Pan, C., Alexander, D., Stampfer, M., and Reed, S. (1994). A novel inhibitor of cyclin-cdk activity detected in transforming growth factor b-arrested epithelial cells. Mol. Cell. Biol. 14, 3683-3694.
44. 1 cell state. Mol. Cell. Biol. 16, 6965-6976.
45. Starostik, P., Chow, K.N.B., and Dean, D. (1996). Transcriptional repression and growth suppression by the p107 pocket protein. Mol. Cell. Biol. 16, 3606-3614.
46. Sudgen, B., Marsh, K., and Yates, J. (1985). A vector that replicates as a plasmid and can be efficiently selected in B-Lymphob lasts transformed by Epstein-Barr virus. Mol. Cell. Biol. 5, 410-413.
47. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
48. Vairo, G., Livingston, D.M., and Ginsberg, D. (1995). Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma family members. Genes Dev. 9, 869-881.
49. Vindelov, L.L., Christensen, I.J., and Nissen, N.I. (1983). A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3, 323-327.
50. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
51. Weintraub, S.J., Chow, K.N.B., Luo, R.X., Zhang, S.H., He, S., and Dean, D. (1995). Mechanism of active transeriptional repression by the retinoblastoma protein. Nature 375, 812-815.
52. Zerfass-Thome, K., Schulze, A., Zwerschke, W., Vogt, B., Helin, K., Bartek, J., Henglein, B., and Jansen-Durr, P. (1997). p27Kip1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17, 407-415.
53. Zhang, H., Hannon, G.J., and Beach, D. (1994). p21-containing cyclin kinase exist in both active and inactive states. Genes Dev. 8, 1750-1758.
54. Zhu, L., Harlow, E., and Dynlacht, B.D. (1995). P107 uses a p21 CIPl-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9, 1740-1752.
55. Zhu, L., van den Huevel, S., Heiin, K., Fattaey, A., Ewen, M., Livingston, D.M., Dyson, N., and Harlow, E. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111-1125.